Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds – an optical coherence tomography substudy of the EVERBIO II trial. (2016). Swiss Medical Weekly, 146(0102), w14274. https://doi.org/10.4414/smw.2016.14274